Yıl: 2020 Cilt: 29 Sayı: 1 Sayfa Aralığı: 7 - 12 Metin Dili: İngilizce DOI: 10.9739/tjvs.2020.570 İndeks Tarihi: 04-10-2020

Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up

Öz:
Objectives: This study aims to present our mid-term experience of treating chronic iliac or femoral total occlusions via percutaneoustransluminal angioplasty (PTA).Patients and methods: Between January 2017 and August 2019, this single-center, retrospective study included 45 patients (40 males,5 females; median age 60 years; range, 33 to 81 years) who underwent PTA due to chronic total occlusion.Results: Of the patients, eight had iliac and 37 had superficial femoral artery occlusion. The technical success rate was 95.5% with a meanfollow-up period 17.2±0.4 months. Bail-out stenting was required in 10 (22.2%) of the lesions and only seven patients (15.5%) neededpercutaneous reintervention at the end of follow-up. Following endovascular interventions, one patient (2.2%) developed seroma, while two(4.4%) developed infections and one (2.2.%) developed a pseudoaneurysm of the femoral artery. Three patients (6.6%) underwent femoropopliteal bypass. A total of 42 patients completed the follow-up. The Kaplan-Meier analysis revealed a primary patency rate of 83.3% andfreedom from reintervention of 95.2% during 17-month follow-up.Conclusion: The endovascular treatment strategy of chronic total occlusions of the iliac and femoral arteries is acceptable with less morbidityand good patency rates. Cardiovascular surgeons should be encouraged in the field of endovascular treatment of peripheral arterial diseaseincluding chronic total occlusions.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Marrocco-Trischitta MM, Bertoglio L, Tshomba Y, Kahlberg A, Marone EM, Chiesa R. The best treatment of juxtarenal aortic occlusion is and will be open surgery. J Cardiovasc Surg (Torino) 2012;53:307-12.
  • 2. Galaria II, Davies MG. Percutaneous transluminal revascularization for iliac occlusive disease: long-term outcomes in TransAtlantic Inter-Society Consensus A and B lesions. Ann Vasc Surg 2005;19:352-60.
  • 3. Ichihashi S, Higashiura W, Itoh H, Sakaguchi S, Nishimine K, Kichikawa K. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II. J Vasc Surg 2011;53:992-9.
  • 4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45:S5-67.
  • 5. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e686-e725.
  • 6. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
  • 7. Timaran CH, Prault TL, Stevens SL, Freeman MB, Goldman MH. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg 2003;38:272-8.
  • 8. Bisdas T, Borowski M, Torsello G; First-Line Treatments in Patients With Critical Limb Ischemia (CRITISCH) Collaborators. Current practice of first-line treatment strategies in patients with critical limb ischemia. J Vasc Surg 2015;62:965-73.
  • 9. Colapinto RF, Stronell RD, Johnston WK. Transluminal angioplasty of complete iliac obstructions. AJR Am J Roentgenol. 1986;146:859-62.
  • 10. Hausegger KA, Lammer J, Klein GE, Flückiger F, Lafer M, Pilger E, et al. Percutaneous recanalization of pelvic artery occlusions--fibrinolysis, PTA, stents. Rofo 1991;155:550-5.
  • 11. Blum U, Gabelmann A, Redecker M, Nöldge G, Dornberg W, Grosser G, et al. Percutaneous recanalization of iliac artery occlusions: results of a prospective study. Radiology 1993;189:536-40.
  • 12. Indes JE, Pfaff MJ, Farrokhyar F, Brown H, Hashim P, Cheung K, et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther 2013;20:443-55.
  • 13. Kavaliauskienė Z, Antuševas A, Kaupas RS, Aleksynas N. Recent advances in endovascular treatment of aortoiliac occlusive disease. Medicina (Kaunas) 2012;48:653-9.
  • 14. Ozkan U, Oguzkurt L, Tercan F. Technique, complication, and long-term outcome for endovascular treatment of iliac artery occlusion. Cardiovasc Intervent Radiol 2010;33:18-24.
  • 15. Araki M, Hirano K, Nakano M, Ito Y, Ishimori H, Yamawaki M, et al. Two-year outcome of the selfexpandable stent for chronic total occlusion of the iliac artery. Cardiovasc Interv Ther 2014;29:40-6.
  • 16. Kashyap VS, Pavkov ML, Bena JF, Sarac TP, O’Hara PJ, Lyden SP, et al. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg 2008;48:1451-7, 1457.e1-3.
  • 17. Sachwani GR, Hans SS, Khoury MD, King TF, Mitsuya M, Rizk YS, et al. Results of iliac stenting and aortofemoral grafting for iliac artery occlusions. J Vasc Surg 2013;57:1030-7.
  • 18. Aihara H, Soga Y, Mii S, Okazaki J, Yamaoka T, Kamoi D, et al. Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with Trans-Atlantic Inter-Society Consensus-II C and D femoropopliteal disease. Circ J 2014;78:457-64.
  • 19. Mayor J, Branco B, Chung J, Baker F, Kougias P, Mills Sr J, et al. Outcome Comparison between Open and Endovascular Management of TASC II D Aortoiliac Occlusive Disease. Presented at the Annual Meeting of the Society for Vascular Surgery (SVS), 2017, San Diego, USA.
APA Yiğit G, Sarıcaoğlu M, Cetinkaya F, Özen A, ISCAN H (2020). Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. , 7 - 12. 10.9739/tjvs.2020.570
Chicago Yiğit Görkem,Sarıcaoğlu Mehmet Cahit,Cetinkaya Ferit,Özen Anıl,ISCAN HAKKI ZAFER Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. (2020): 7 - 12. 10.9739/tjvs.2020.570
MLA Yiğit Görkem,Sarıcaoğlu Mehmet Cahit,Cetinkaya Ferit,Özen Anıl,ISCAN HAKKI ZAFER Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. , 2020, ss.7 - 12. 10.9739/tjvs.2020.570
AMA Yiğit G,Sarıcaoğlu M,Cetinkaya F,Özen A,ISCAN H Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. . 2020; 7 - 12. 10.9739/tjvs.2020.570
Vancouver Yiğit G,Sarıcaoğlu M,Cetinkaya F,Özen A,ISCAN H Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. . 2020; 7 - 12. 10.9739/tjvs.2020.570
IEEE Yiğit G,Sarıcaoğlu M,Cetinkaya F,Özen A,ISCAN H "Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up." , ss.7 - 12, 2020. 10.9739/tjvs.2020.570
ISNAD Yiğit, Görkem vd. "Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up". (2020), 7-12. https://doi.org/10.9739/tjvs.2020.570
APA Yiğit G, Sarıcaoğlu M, Cetinkaya F, Özen A, ISCAN H (2020). Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. Turkish journal of vascular surgery, 29(1), 7 - 12. 10.9739/tjvs.2020.570
Chicago Yiğit Görkem,Sarıcaoğlu Mehmet Cahit,Cetinkaya Ferit,Özen Anıl,ISCAN HAKKI ZAFER Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. Turkish journal of vascular surgery 29, no.1 (2020): 7 - 12. 10.9739/tjvs.2020.570
MLA Yiğit Görkem,Sarıcaoğlu Mehmet Cahit,Cetinkaya Ferit,Özen Anıl,ISCAN HAKKI ZAFER Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. Turkish journal of vascular surgery, vol.29, no.1, 2020, ss.7 - 12. 10.9739/tjvs.2020.570
AMA Yiğit G,Sarıcaoğlu M,Cetinkaya F,Özen A,ISCAN H Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. Turkish journal of vascular surgery. 2020; 29(1): 7 - 12. 10.9739/tjvs.2020.570
Vancouver Yiğit G,Sarıcaoğlu M,Cetinkaya F,Özen A,ISCAN H Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up. Turkish journal of vascular surgery. 2020; 29(1): 7 - 12. 10.9739/tjvs.2020.570
IEEE Yiğit G,Sarıcaoğlu M,Cetinkaya F,Özen A,ISCAN H "Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up." Turkish journal of vascular surgery, 29, ss.7 - 12, 2020. 10.9739/tjvs.2020.570
ISNAD Yiğit, Görkem vd. "Endovascular treatment of chronic total occlusion of iliac/femoral arteries: Mid-term follow-up". Turkish journal of vascular surgery 29/1 (2020), 7-12. https://doi.org/10.9739/tjvs.2020.570